dengu
viru
denv
pathogen
high
impact
human
health
replic
wide
rang
cell
involv
immun
respons
effici
infect
human
denv
must
evad
inhibit
fundament
element
innat
immun
system
name
type
interferon
respons
denv
circumv
host
immun
respons
express
protein
antagon
cellular
innat
immun
recent
document
inhibit
type
ifn
product
proteolyt
activ
denv
proteas
complex
human
monocyt
deriv
dendrit
cell
mddc
present
report
identifi
human
adaptor
molecul
sting
target
proteas
complex
character
mechan
inhibit
type
ifn
product
primari
human
mddc
viral
factor
use
differ
human
mous
primari
cell
lack
sting
show
enhanc
denv
replic
convers
mutat
version
sting
cleav
denv
proteas
induc
higher
level
type
ifn
infect
denv
addit
show
denv
abl
degrad
mous
version
sting
phenomenon
sever
restrict
replic
denv
mous
cell
suggest
sting
play
key
role
inhibit
denv
infect
spread
mice
viral
infect
vast
impact
human
health
result
hundr
thousand
death
yearli
replic
spread
intracellular
pathogen
subvert
host
cellular
defens
machineri
dengu
viru
denv
preval
arboviru
human
product
infect
cell
involv
immun
respons
monocyt
b
cell
macrophag
dendrit
cell
dc
among
other
like
virus
denv
evolv
order
inhibit
evad
differ
aspect
innat
immun
system
first
line
human
defens
microb
dc
antigen
present
cell
apc
first
cell
interact
viru
bite
infect
mosquito
infect
cell
induc
activ
result
migrat
lymph
node
viru
infect
suscept
cell
kinet
infect
differ
cell
immun
system
well
document
due
lack
immunecompet
mous
model
dengu
diseas
nevertheless
mice
defect
type
ifn
signal
one
accept
current
model
dengu
diseas
shown
dc
macrophag
product
infect
denv
review
denv
singl
strand
rna
viru
posit
polar
enter
cytoplasm
host
cell
releas
genom
synthes
polyprotein
use
cellular
machineri
first
event
viral
cycl
denv
polyprotein
cleav
viral
proteas
complex
cellular
proteas
includ
furin
process
viral
protein
abil
rearrang
er
membran
creat
microenviron
necessari
product
de
novo
synthes
viral
genom
rna
event
denv
accumul
product
conserv
molecular
structur
like
rna
moieti
doubl
strand
rna
also
refer
pathogen
associ
molecular
pattern
pamp
foreign
molecul
ligand
differ
cellular
receptor
engag
recognit
known
pattern
recognit
receptor
prr
prr
mainli
divid
two
differ
class
depend
local
associ
either
membran
cytoplasm
tolllik
receptor
tlr
famili
compos
membran
protein
domain
design
detect
extracellular
pamp
hand
cytosol
dexdhbox
rna
helicas
protein
contain
caspaserecruit
domain
card
refer
rigi
detect
specif
pamp
present
cytoplasm
last
two
cytoplasm
sensor
togeth
tlr
famili
member
describ
far
relev
denv
sensor
recognit
mention
pamp
ctermin
helicas
domain
rigi
undergo
conform
chang
expos
card
domain
promot
interact
differ
downstream
molecul
one
well
studi
downstream
molecul
refer
also
known
mav
cardif
visa
locat
outer
membran
mitochondria
transmit
signal
via
differ
molecul
includ
tumor
necrosi
factor
receptor
associ
factor
ikb
kinas
ikk
famili
member
ikka
ikkb
ikk
among
cellular
factor
review
recent
three
differ
group
use
cdna
librari
screen
gene
induc
ifnb
promot
describ
adaptor
protein
local
endoplasm
reticulum
er
protein
name
stimul
interferon
gene
sting
mediat
activ
mita
endoplasm
reticulum
ifn
stimul
eri
also
protein
refer
myp
previous
identifi
mediat
antimajor
histocompat
complex
ii
monoclon
antibodyinduc
apoptosi
blymphoma
cell
sting
highli
express
sever
immun
cell
includ
macrophag
dc
well
endotheli
epitheli
cell
protein
interact
rigi
signal
mediat
adaptor
independ
sens
tlr
famili
member
two
recent
report
document
sting
involv
pathway
mediat
detect
pathogen
dna
genom
role
direct
sensor
cyclic
dinucleotid
signal
molecul
produc
exclus
bacteria
archea
activ
sting
stimuli
lead
reloc
er
perinuclear
vesicl
contain
subunit
exocyst
complex
follow
phosphoryl
subsequ
activ
transcript
factor
nfkb
transloc
nucleu
complex
induc
express
type
ifn
proinflammatori
cytokin
remark
hallmark
highli
virul
human
pathogen
abil
acquir
evolut
inhibit
innat
immun
respons
express
viral
factor
affect
one
sever
step
describ
signal
cascad
notori
exampl
influenza
viru
protein
target
rigi
degrad
minim
sens
influenza
viru
pamp
prr
hepat
c
viru
proteas
complex
cleav
adaptor
interrupt
signal
end
activ
nfkb
subsequ
product
type
ifn
human
hepatocyt
group
document
denv
weak
induc
type
interferon
human
dc
particular
compar
virus
compet
produc
cytokin
larg
amount
newcastl
diseas
viru
ndv
semliki
forest
viru
sfv
lack
type
ifn
product
dc
infect
denv
result
impair
abil
dc
prime
cell
toward
immun
effect
revers
addit
ifnb
nevertheless
denv
abl
induc
express
proinflammatori
cytokin
earli
time
post
infect
hypothes
strategi
use
viru
attract
cell
site
infect
allow
express
chemoattract
infect
cell
group
describ
infect
denv
induc
phosphoryl
human
primari
cell
result
inhibit
type
ifn
product
subsequ
report
examin
abil
denvinfect
dc
respond
varieti
type
ifntrigg
signal
use
potent
stimul
ndv
sev
sfv
ligand
poli
c
effect
viral
dose
depend
take
place
earli
hour
denv
infect
also
show
inhibit
ifnab
product
ndv
infect
denvinfect
dc
bystand
effect
impli
activ
role
denvinfect
dc
popul
inhibit
ifnab
use
ndv
vector
strategi
express
individu
denv
nonstructur
protein
show
recombin
ndv
express
proteas
complex
inhibit
ifna
express
infect
mddc
compar
ndv
alon
similar
result
obtain
use
ifnb
promot
activ
assay
cell
catalyt
inact
mutant
show
diminish
inhibit
phenotyp
highlight
import
role
proteas
activ
protein
inhibitor
type
ifn
product
interestingli
proteolyt
core
consist
last
amino
acid
first
amino
acid
enough
reduc
activ
ifnb
promot
strong
stimulu
sendai
viru
sev
infect
denv
also
shown
express
inhibitor
type
ifn
signal
cascad
shown
encod
least
four
nonstructur
protein
target
differ
compon
pathway
remark
exampl
proteasom
degrad
human
phenomenon
occur
mous
cell
make
mous
restrict
factor
denv
replic
anim
summari
denv
success
inhibit
two
fundament
step
innat
immun
system
inhibit
type
ifn
product
signal
way
denv
reduc
express
hundr
interferon
induc
gene
would
otherwis
establish
antivir
state
control
spread
infect
host
present
report
describ
mechan
inhibit
type
ifn
product
denv
primari
human
mous
cell
identifi
human
adaptor
molecul
sting
target
dengu
viru
denv
pathogen
high
impact
human
health
replic
wide
rang
cell
immun
system
effici
infect
human
denv
must
evad
inhibit
fundament
element
innat
immun
system
name
type
interferon
respons
ifn
thu
denv
inhibit
type
ifn
signal
describ
sever
group
type
ifn
product
describ
group
document
inhibit
type
ifn
product
human
monocyt
deriv
dendrit
cell
mddc
otherwis
strong
cytokin
chemokin
profil
cell
proteas
complex
denv
function
antagonist
type
ifn
product
proteolyt
activ
necessari
event
identifi
human
adaptor
molecul
sting
target
proteas
complex
character
mechan
inhibit
type
ifn
product
primari
human
mddc
mediat
viral
factor
also
describ
denv
degrad
mous
version
sting
phenomenon
strictli
restrict
replic
denv
mous
cell
suggest
sting
play
key
role
inhibit
denv
infect
spread
mice
denv
proteas
complex
demonstr
proteolyt
activ
viral
factor
crucial
cleavag
degrad
sting
phenomenon
impair
product
type
ifn
denv
infect
cell
furthermor
show
denv
abl
cleav
mous
version
sting
use
sting
doubl
knockout
mous
embryon
fibroblast
mef
human
dendrit
cell
demonstr
relev
role
host
factor
restrict
denv
replic
mous
cell
first
report
show
sting
target
cleavag
degrad
viral
protein
inhibit
innat
immun
respons
host
restrict
factor
viru
infect
primari
cell
previou
result
laboratori
show
dengu
viru
inhibit
type
ifn
product
human
primari
dendrit
cell
inhibit
requir
proteolyt
activ
proteas
complex
order
identifi
potenti
target
perform
bioinformat
search
potenti
denv
proteas
cleavag
site
contain
within
member
type
ifn
pathway
identifi
put
cleavag
site
sever
known
member
type
ifn
pathway
see
tabl
test
factor
shown
tabl
suscept
cleav
denv
proteas
observ
sting
cleav
experiment
set
data
shown
figur
gener
wild
type
proteolyt
inact
version
figur
direct
mutagenesi
use
analyz
potenti
cleavag
sting
denv
proteas
complex
compar
human
amino
acid
sequenc
human
sting
mous
counterpart
notic
put
cleavag
site
hsting
situat
begin
transmembran
domain
figur
absent
mous
sting
order
test
suscept
human
mous
sting
protein
proteolyt
cleavag
degrad
coexpress
ctermin
hatag
sting
alongsid
wild
type
catalyt
activ
proteolyt
inact
version
cell
figur
analyz
western
blot
figur
presenc
wt
observ
fulllength
kda
human
sting
addit
band
kd
consist
ctermin
region
product
cleavag
occur
within
first
aa
sting
figur
addit
band
visibl
mous
version
sting
catalyt
inact
use
figur
put
cleavag
site
denv
lie
close
conserv
cystein
motif
redox
motif
recent
describ
requir
dimer
sting
subsequ
signal
type
ifn
product
pathway
regardless
suscept
cleavag
denv
complex
human
mous
version
sting
coimmunoprecipit
wt
denv
complex
proteolyt
inact
mutant
figur
lane
map
put
cleavag
site
human
sting
denv
complex
mutat
sequenc
correspond
first
three
amino
acid
human
site
rrg
shown
figur
hsting
red
sequenc
correspond
amino
acid
hcm
found
mous
version
sting
shown
figur
msting
recombin
version
sting
cotransfect
cell
wt
mutant
version
proteas
abil
denv
proteas
cleav
sting
figur
lane
drastic
reduc
mous
sequenc
present
hsting
figur
lane
data
confirm
requir
amino
acid
rrg
effici
cleavag
sting
denv
howev
replac
correspond
amino
acid
sequenc
mous
sting
ihcm
human
put
cleavag
sequenc
lrrg
render
mous
sting
suscept
cleavag
denv
proteas
figur
lane
suggest
addit
flank
amino
acid
requir
cleavag
altogeth
result
strongli
suggest
sting
target
human
cell
possibl
restrict
factor
denv
infect
mous
test
whether
endogen
sting
undergo
process
overexpress
experi
cell
infect
human
mddc
strain
analyz
cell
lysat
western
blot
differ
time
point
figur
infect
mddc
denv
result
degrad
sting
could
detect
hour
post
infect
hpi
figur
lane
correl
peak
express
level
detect
specif
antibodi
expect
degrad
sting
observ
mddc
treat
uvinactiv
denv
mock
treat
cell
figur
data
demonstr
denv
cleavag
endogen
human
sting
occur
cell
relev
denv
infect
mddc
therefor
potenti
play
crucial
role
inhibit
type
ifn
product
next
investig
whether
sting
cleavag
denv
impact
abil
mediat
signal
necessari
type
ifn
product
transfect
cell
either
hsting
figur
msting
figur
three
differ
version
denv
proteas
wild
type
proteolyt
inact
version
proteolyt
core
alongsid
luciferas
report
construct
driven
either
ifnb
promot
ifnbluc
three
bind
site
kindli
provid
dr
megan
shaw
shown
figur
schemat
shown
figur
cleavag
hsting
denv
greatli
inhibit
abil
activ
report
construct
transfect
mutant
version
proteas
convers
denv
minim
impact
abil
msting
induc
activ
either
report
construct
use
observ
denv
inhibit
human
adaptor
use
posit
control
induc
ifnb
promot
demonstr
inhibit
dengu
infect
occur
upstream
adaptor
data
shown
take
togeth
data
demonstr
cleavag
hsting
denv
preclud
induct
type
ifn
respons
moreov
valid
observ
result
human
primari
cell
use
e
coli
dna
known
induc
sting
signal
treat
human
mddc
previous
infect
denv
uvinactiv
denv
mock
treat
shown
schemat
figur
figur
show
live
denv
uv
inactiv
denv
abl
inhibit
induct
ifnb
ifna
ligand
human
mddc
valid
result
describ
use
ifnb
promot
assay
primari
cell
model
measur
ifnab
product
upon
infect
mddc
either
denv
semliki
forest
viru
sfv
express
denv
proteas
complex
mutant
version
proteas
control
consist
earlier
report
human
mddc
infect
strain
unabl
produc
ifnab
furthermor
induc
significantli
lower
level
ifnab
mrna
figur
interestingli
induc
significantli
higher
express
tnfa
earli
time
postinfect
compar
control
figur
shown
previous
would
suggest
involv
proteas
complex
express
proinflammatori
cytokin
expect
infect
mddc
denv
upregul
express
sting
cell
figur
figur
show
kinet
infect
denv
mddc
peak
viral
rna
hpi
contrast
sfv
vector
use
studi
show
low
level
viral
rna
late
time
treatment
figur
sinc
vector
replic
defici
infect
mous
bone
marrowdc
bmdc
use
virus
analyz
gene
induct
profil
cell
expect
infect
bmdc
denv
rapidli
control
consist
inabl
denv
infect
mous
cell
show
opposit
kinet
viral
rna
synthesi
compar
observ
pattern
human
dc
modest
induct
cytokin
figur
sfv
alphaviru
replic
mous
cell
dc
particular
context
exhibit
higher
induct
ifnab
gene
compar
control
show
opposit
profil
observ
human
dc
induc
higher
level
ifnab
gene
figur
kinet
infect
sfv
vector
mous
dc
figur
show
low
level
viral
rna
consist
lack
product
infect
cell
observ
phenomenon
agre
inabl
recombin
cleav
mous
sting
decreas
activ
ifnb
promot
induc
adaptor
protein
figur
explor
sting
impact
denv
replic
mous
cell
use
wt
sting
sting
doubl
knockout
sting
mous
embryon
fibroblast
mef
first
infect
wt
sting
mef
two
differ
strain
ngc
strain
obtain
sever
passag
mous
brain
moi
measur
abil
two
strain
induc
ifnb
product
replic
cell
releas
infecti
particl
cell
figur
strain
induc
significantli
higher
level
ifnb
wt
mef
compar
sting
mef
figur
underlin
relev
sting
signal
type
ifn
upon
infect
denv
consist
observ
low
induct
ifnb
sting
mef
permiss
denv
replic
despit
high
moi
use
replic
denv
ngc
rapidli
control
wt
mef
figur
product
infecti
particl
two
strain
wt
sting
mef
measur
plaqu
assay
show
ko
mef
permiss
denv
infect
wt
mef
differ
peak
infect
figur
test
whether
observ
independ
high
moi
viral
strain
use
repeat
infect
use
differ
denv
serotyp
strain
strain
strain
moi
similar
result
data
shown
result
like
due
inabl
denv
inhibit
type
ifn
signal
mous
cell
establish
antivir
state
mutat
cleavag
site
restor
abil
sting
induc
type
ifn
product
upon
denv
infect
confirm
relev
sting
cleavag
inhibit
type
ifn
product
upon
denv
infect
transduc
sting
mef
lentivirus
express
either
wt
human
sting
stingwt
mutant
uncleav
version
harbor
mous
sting
sequenc
site
stingmut
figur
twentyfour
hour
transduct
mef
infect
moi
strain
ngc
mock
treat
level
ifnb
ifna
viral
rna
measur
qrtpcr
total
rna
extract
cell
differ
time
post
infect
figur
schemat
represent
lentivirus
use
shown
figur
experi
shown
figur
mef
express
uncleav
version
sting
stingmut
express
significantli
higher
level
ifnb
mrna
compar
mef
express
wt
sting
stingwt
control
mef
gfp
confirm
cleavag
sting
necessari
inhibit
ifnb
product
infect
cell
induct
ifnb
detect
earli
hpi
infect
two
strain
also
induc
higher
level
ifna
mrna
mef
express
stingmut
mef
express
stingwt
gfp
control
figur
experiment
condit
replic
mous
adapt
ngc
increas
sting
mef
express
wild
type
sting
compar
stingmut
figur
case
strain
signific
increas
replic
observ
sting
mef
gfp
hpi
signific
differ
observ
mef
express
two
version
sting
presum
due
high
level
lentiviralexpress
sting
could
overwhelm
abil
non
mouseadapt
denv
strain
replic
system
figur
shown
figur
lack
sting
cleavag
suffici
increas
express
type
ifn
mef
infect
denv
valid
result
primari
human
cell
transduc
mddc
three
differ
donor
stingexpress
lentivirus
gfponli
control
figur
sting
transduc
dc
infect
moi
assess
product
ifnb
cell
shown
figur
show
one
repres
donor
three
signific
differ
level
stingwt
stingmut
mrna
demonstr
differ
antivir
effect
observ
two
differ
version
sting
independ
express
level
protein
upon
infect
dc
express
stingmut
produc
higher
level
ifnb
compar
stingwt
gfp
control
show
statist
signific
hpi
induct
ifnb
messeng
rna
detect
earli
hpi
agreement
result
describ
mef
figur
data
confirm
detect
denv
infect
dc
take
place
earli
time
post
infect
sting
cleavag
denv
fundament
inhibit
signal
mediat
adaptor
human
cell
next
measur
denv
replic
kinet
found
viral
rna
level
significantli
lower
dc
overexpress
stingmut
compar
stingwt
gfp
control
figur
suggest
inabl
denv
cleav
mutant
sting
inhibit
induct
type
ifn
direct
impact
replic
kinet
accumul
viral
rna
cell
determin
sting
impact
denv
replic
primari
human
mddc
use
rna
interfer
rnai
silenc
endogen
express
decreas
sting
mrna
level
observ
specif
sirna
use
compar
two
scrambl
control
sirna
figur
expect
previous
observ
upregul
sting
denv
infect
control
sting
sirna
figur
consequ
reduct
sting
express
result
increas
denv
replic
illustr
figur
viral
progeni
releas
infect
mddc
quantifi
plaqu
assay
six
donor
treat
sting
specif
sirna
show
viral
product
experiment
condit
howev
scrambl
sirna
use
three
six
donor
releas
detect
viral
progeni
supernat
figur
data
shown
figur
correspond
donor
figur
taken
togeth
data
confirm
sting
crucial
restrict
factor
denv
replic
human
dendrit
cell
sinc
silenc
increas
level
denv
replic
cell
differ
popul
cell
isol
human
blood
subsequ
infect
moi
h
infect
supernat
collect
rna
extract
cell
rna
detect
cell
test
includ
plasmacytoid
dc
pdc
b
cell
blood
circul
dc
cdc
monocyt
well
monocytederiv
dc
mddc
figur
also
analyz
cytokin
chemokin
express
profil
cell
qrtpcr
data
shown
multiplex
elisa
figur
supernat
hpi
observ
mark
chemokin
respons
monocyt
mddc
b
cell
cdc
earli
time
point
figur
howev
pdc
show
signific
chemokin
profil
infect
time
point
figur
interestingli
signific
type
ifn
product
observ
cell
test
qrtpcr
data
shown
elisa
figur
data
suggest
coordin
distinct
kinet
infect
differ
cell
popul
blood
lack
type
ifn
product
cell
infect
viru
least
earli
time
point
earli
time
point
hpi
chosen
obtain
suffici
number
pdc
sinc
cell
short
halfliv
downregul
specif
cell
surfac
marker
rapid
fashion
nevertheless
previous
report
earli
hpi
pdc
abl
produc
type
ifn
infect
virus
ndv
rule
lack
type
ifn
product
result
lack
cell
cell
interact
infect
whole
pbmc
moi
h
infect
cell
supernat
collect
figur
show
multiplex
elisa
data
cell
supernat
cultur
clear
respons
infect
pbmc
consist
strong
signatur
observ
sera
patient
detect
ifna
secret
infect
pbmc
figur
suggest
may
inhibit
type
ifn
product
suscept
cell
within
cultur
macrophag
shown
support
denv
infect
anim
model
propos
play
import
role
earli
phase
dengu
viru
infect
test
monocytederiv
macrophag
mdm
infect
denv
abl
produc
type
ifn
figur
show
macrophag
effici
infect
denv
earli
peak
replic
produc
tnfa
denv
infect
sfv
express
wt
mutant
version
denv
proteas
complex
figur
experiment
condit
unabl
detect
ifna
releas
macrophag
denv
infect
interestingli
compar
mddc
infect
virus
figur
macrophag
produc
least
lower
level
ifna
sfv
infect
inhibitori
effect
denv
proteas
system
less
appar
activ
innat
immun
due
detect
viral
replic
product
cell
lead
express
hundr
antivir
gene
control
spread
infect
inhibit
differ
step
implic
molecular
pathway
virus
matter
extens
studi
sever
year
demonstr
other
group
denv
inhibit
product
signal
type
ifn
express
viral
protein
way
denv
mitig
immun
respons
induc
host
upon
infect
identifi
human
adaptor
molecul
sting
protein
predomin
role
recognit
denv
innat
immun
system
adaptor
protein
describ
resid
er
cellular
organel
intim
relat
denv
replic
process
also
sting
describ
part
trap
translocon
associ
protein
complex
associ
rigi
two
protein
relev
role
viral
detect
ishikawa
et
al
also
describ
inhibit
sting
mediat
ifnb
product
yellow
fever
viru
yfv
howev
tri
replic
result
use
denv
viral
protein
unabl
decreas
induct
luciferas
mediat
sting
ifnb
promot
assay
data
shown
coexpress
experi
human
sting
denv
proteas
complex
observ
specif
cleavag
site
describ
put
target
denv
gener
cleav
band
approxim
kda
figur
interestingli
analysi
sequenc
align
human
sting
mous
version
observ
drastic
differ
amino
acid
sequenc
region
shown
figur
inabl
cleav
mous
sting
denv
confirm
coexpress
experi
figur
furthermor
impact
sting
cleavag
signal
ifnb
product
pathway
subsequ
demonstr
use
ifnb
promot
system
figur
experi
reduct
luciferas
induct
observ
human
sting
suggest
cleavag
confirm
wb
show
figur
impair
abil
adaptor
induc
ifnb
recent
jin
et
al
describ
seri
mutat
hsting
implic
activationdimer
subsequ
induct
interferon
interestingli
two
cystein
locat
fundament
proper
induct
type
ifn
stimul
could
interest
investig
presenc
mutat
cleavag
site
sting
denv
human
popul
identifi
natur
resist
denv
infect
manuscript
review
yu
colleagu
report
overexpress
experi
denv
proteas
cleav
adaptor
molecul
mita
present
report
provid
import
data
role
adaptor
molecul
primari
human
mous
cell
context
denv
infect
also
confirm
cleavag
degrad
sting
denv
proteas
human
mddc
context
denv
infect
sinc
import
valid
find
relev
primari
cell
system
viru
infect
figur
primari
human
cell
well
mous
cell
mef
dc
also
found
presenc
human
sting
allow
greater
denv
replic
presenc
mous
sting
seem
restrict
denv
replic
figur
figur
figur
also
show
proteas
denv
specif
human
sting
mous
homologu
protein
figur
figur
suggest
sting
may
import
restrict
factor
mice
sever
viral
proteas
describ
protein
modul
cellular
pathway
allow
mani
virus
modifi
intra
extracellular
environ
promot
optim
condit
replic
spread
remark
characterist
observ
earli
time
infect
denv
lack
ifnab
induct
robust
induct
proinflammatori
cytokin
like
tnfa
describ
previou
work
denv
infect
abrog
phosphoryl
impact
nfkb
activ
use
recombin
virus
express
observ
clear
effect
induct
tnfa
human
dc
similar
observ
denv
infect
figur
figur
also
inhibit
luciferas
activ
driven
promot
consider
effici
compar
ifnbpromot
sinc
harbor
site
transcript
factor
ifnbluc
also
respons
element
nfkb
transcript
factor
figur
furthermor
ishikawa
et
al
overexpress
sting
cell
presenc
differ
promot
drive
luciferas
gene
interestingli
sting
stimul
ifnb
promot
respons
element
prdiiiiluc
nfkb
respons
promot
nfkbluc
observ
suggest
sting
fundament
involv
phosphoryl
experiment
condit
show
fold
less
influenc
nfkb
induct
taken
togeth
observ
suggest
denv
proteas
inhibit
ifnb
product
cleavag
adaptor
sting
without
modifi
observ
nfkb
activ
induc
infect
denv
work
explor
impact
induct
nfkb
activ
infect
cell
would
confirm
put
role
viral
factor
modul
innat
immun
respons
induct
proinflammatori
cytokin
hallmark
phenomenon
observ
infect
denv
becom
increasingli
clear
sting
crucial
adaptor
immun
cell
infect
differ
virus
hiv
denv
among
other
virus
requir
activ
target
cell
order
establish
infect
case
denv
induc
viremia
host
nevertheless
virus
need
limit
inhibit
product
type
ifn
infect
cell
avoid
establish
antivir
state
cell
sting
could
instrument
type
viru
infect
sinc
discrimin
induct
type
ifn
activ
nfkb
pathway
along
line
report
show
novel
mechan
inhibit
ifn
product
rna
viru
name
denv
target
sting
inhibit
type
ifn
nfkb
pathway
denv
induc
specif
profil
infect
human
mddc
suscept
primari
cell
allow
viru
effici
reach
lymph
node
spread
infect
host
culmin
product
viremia
experi
perform
context
primari
infect
denv
sinc
believ
earli
event
primari
infect
dictat
qualiti
adapt
immun
respons
outcom
infect
target
dc
inhibit
product
type
ifn
cell
denv
may
abl
effici
modul
gener
adapt
immun
respons
establish
infect
host
propos
denv
infect
may
respons
control
earli
viral
replic
type
ifn
product
ifn
signal
pathway
jakstat
may
control
late
viral
replic
type
ifn
product
denv
infect
cell
possibl
interact
sting
may
disrupt
denv
target
sting
mayinhibit
type
ifn
product
earli
denv
infect
suscept
cell
although
shown
directli
interact
experi
requir
understand
complex
interplay
differ
signal
molecul
human
primari
cell
infect
denv
experi
demonstr
primari
human
cell
implic
dengu
viru
infect
dendrit
cell
macrophag
monocyt
b
cell
support
denv
replic
although
differ
level
interestingli
denv
infect
induc
type
ifn
product
human
primari
cell
test
figur
differ
blood
cell
may
play
differ
role
denv
infect
human
involv
initi
infect
final
stage
viremia
also
sinc
mous
model
support
denv
replic
recapitul
dengu
symptom
defici
type
ifn
respons
reconstitut
human
immun
cell
inhibit
type
ifn
infect
cell
seem
crucial
establish
infect
denv
data
differ
cell
blood
also
show
inhibit
type
ifn
product
denv
dc
specif
phenomenon
figur
inabl
denv
replic
wild
type
mous
cell
well
document
mani
attempt
made
develop
compet
anim
model
studi
denv
infect
data
present
manuscript
show
abil
denv
replic
sting
mef
figur
open
new
approach
develop
mous
model
studi
denv
infect
also
highlight
requir
type
ifn
product
innat
immun
system
control
invad
pathogen
ashour
et
al
describ
adaptor
restrict
factor
denv
replic
mous
cell
base
combin
data
interest
approach
would
develop
transgen
mous
model
human
sting
approach
could
provid
immun
compet
mous
model
denv
elimin
two
potenti
bottleneck
exist
denv
replic
mice
anim
protocol
use
studi
review
approv
univers
miami
institut
anim
care
use
committe
iacuc
iacuc
protocol
host
defens
regul
interferon
product
sting
univers
miami
anim
welfar
assur
file
offic
laboratori
anim
welfar
olaw
nation
institut
health
assur
number
effect
juli
addit
juli
council
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
intern
continu
univers
miami
full
accredit
vero
mous
embryon
fibroblast
mef
cultur
dulbecco
modifi
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
babi
hamster
kidney
cell
bhk
grown
glasgow
minim
essenti
medium
mem
supplement
fb
mm
hepe
mosquito
cell
deriv
aed
albopictu
clone
expand
rpmi
medium
fb
media
supplement
uml
lglutamin
mgml
penicillinstreptomycin
tissu
cultur
reagent
purchas
invitrogen
dengu
viru
serotyp
strain
new
guinea
c
use
studi
denv
grown
insect
cell
day
describ
elsewher
briefli
cell
infect
multipl
infect
moi
day
infect
cell
supernat
collect
clarifi
store
titer
denv
stock
determin
limitingdilut
plaqu
assay
bhk
cell
semliki
forest
viru
sfv
express
gfp
gener
describ
previous
titrat
bhk
cell
immunofluoresc
lentivir
vector
construct
built
use
convent
molecular
biolog
techniqu
briefli
human
sting
cdna
pcr
amplifi
hsting
clone
lentivir
vector
deriv
phr
sin
csgw
figur
mutat
cleavag
site
posit
hsting
obtain
overlap
pcr
residu
rrg
chang
correspond
murin
sequenc
hcm
lentivir
vector
deriv
virus
obtain
transfect
hek
plasmid
encod
sting
gagpol
vsvg
respect
viral
supernat
harvest
hour
posttransfect
mm
filter
concentr
g
hour
sucros
cushion
frozen
use
monocyt
pdc
b
cell
circul
dc
cdc
isol
blood
healthi
donor
new
york
blood
center
use
miltenyi
isol
kit
clinimac
monocyt
kit
pdc
kit
cdc
b
cell
isol
part
kit
isol
cdc
accord
manufactur
instruct
puriti
cell
popul
test
flow
cytometri
describ
routin
cell
pdc
mddc
cdc
sampl
isol
cell
popul
infect
indic
moi
total
volum
ml
dc
media
hour
c
dc
media
supplement
hs
ad
final
concentr
cellsml
cell
incub
remaind
infect
c
indic
time
cell
supernat
collect
cell
pellet
use
rna
extract
whole
pbmc
use
ficol
centrifug
sampl
pbmc
infect
moi
left
uninfect
hour
dc
media
hs
ad
eighteen
hpi
supernat
collect
isol
differ
cell
popul
infect
carri
describ
human
mddc
obtain
healthi
human
blood
donor
new
york
blood
center
follow
standard
protocol
previous
describ
describ
briefli
ficollhypaqu
gradient
centrifug
cell
isol
mononuclear
fraction
use
mac
isol
kit
milteni
biotec
accord
manufactur
direct
cell
differenti
dc
incub
day
dc
medium
rpmi
supplement
uml
lglutamin
gml
penicillinstreptomycin
mm
sodium
pyruv
presenc
uml
human
granulocytemacrophag
colonystimul
factor
gmcsf
peprotech
uml
human
interleukin
peprotech
fb
hyclon
gener
mdm
monocyt
cultur
presenc
uml
human
granulocytemacrophag
colonystimul
factor
gmcsf
day
media
replenish
concentr
gmcsf
day
puriti
cell
popul
confirm
flow
cytometri
analysi
least
mddc
mdm
femur
tibia
wildtyp
mice
jackson
soak
ethanol
wash
rpmi
invitrogen
epiphys
cut
expos
bone
marrow
bone
flush
rpmi
supplement
fetal
bovin
serum
fb
extract
bone
marrow
cell
pellet
centrifug
wash
rpmi
resuspend
ammonium
chlorid
red
blood
cell
lysi
buffer
rbc
lysi
perform
minut
room
temperatur
stop
rpmifb
cell
collect
centrifug
bone
marrow
cell
seed
dish
rpmi
contain
fb
uml
penicillin
invitrogen
mgml
streptomycin
invitrogen
ngml
gmcsf
peprotech
ngml
ebiosci
mm
betamercaptoethanol
biorad
cell
cultur
day
degre
c
fresh
media
ad
everi
day
human
mous
dc
obtain
describ
day
cultur
sampl
cell
resuspend
ml
dcmedium
infect
min
indic
moi
viru
dilut
dc
media
dc
medium
mock
group
total
volum
ml
adsorpt
period
dc
medium
supplement
fb
ad
final
volum
ml
cell
incub
appropri
time
sirna
transfect
dengu
infect
human
mddc
mddc
seed
per
well
well
plate
transfect
correspond
sirna
use
stemfect
rna
transfect
kit
stemgent
accord
manufactur
instruct
chemic
synthes
sirna
duplex
obtain
origen
technolog
inc
sequenc
sting
sirna
oligonucleotid
use
studi
follow
sist
two
random
noncod
control
sirna
use
qiagen
univers
scrambl
neg
control
sirna
duplex
origen
technolog
inc
h
transfect
cell
infect
dengu
viru
moi
briefli
cell
centrifug
min
media
remov
ml
rpmi
contain
appropri
amount
viru
ad
plate
incub
min
ml
rpmi
fb
ad
cell
incub
indic
hour
subsequ
cell
recov
centrifug
min
cell
pellet
lyse
rna
isol
plate
monocyt
transduc
previous
describ
brief
freshli
isol
monocyt
transduc
vsvg
pseudotyp
siv
vlp
lentivir
vector
construct
h
spinocul
presenc
mgml
polybren
sigma
subsequ
cell
wash
resuspend
regular
growth
medium
describ
gener
monocyt
deriv
human
dendrit
cell
incub
day
stimul
day
posttransduct
mddc
infect
denv
describ
cell
pellet
collect
indic
time
point
lyse
rna
isol
cell
transfect
use
lipofectamin
reagent
invitrogen
accord
manufactur
protocol
type
ifn
product
antagonist
assay
perform
describ
previous
use
ifnbluc
cell
seed
plate
transient
transfect
ng
luciferas
report
plasmid
togeth
total
ng
variou
express
plasmid
empti
control
plasmid
intern
control
ng
prltk
transfect
simultan
h
later
luciferas
activ
total
cell
lysat
measur
use
dualluciferas
report
assay
system
promega
accord
manufactur
direct
transfect
cell
infect
human
dc
perform
describ
cell
lysat
obtain
incub
cell
ripa
lysi
buffer
sigma
aldrich
supplement
complet
proteas
inhibitor
roch
resuspend
total
ml
laemmli
sampl
buffer
biorad
crude
lysat
either
boil
min
incub
min
kept
ice
sampl
load
polyacrylamidesd
gel
protein
electrophoret
separ
convent
method
protein
transfer
nitrocellulos
blot
incub
antiha
antiflag
antiactin
antigapdh
sigma
aldrich
rabbit
polyclon
antibodi
antihst
antidenv
kind
gift
dr
andrea
gamarnik
develop
use
snap
id
detect
system
millipor
follow
manufactur
instruct
antibodyprotein
complex
detect
use
western
light
chemiluminesc
system
perkin
elmer
rna
differ
cell
extract
use
trizol
invitrogen
follow
treatment
dnase
use
dnafre
ambion
concentr
evalu
spectrophotomet
nm
ng
rna
revers
transcrib
use
iscript
cdna
synthesi
kit
biorad
accord
manufactur
instruct
evalu
express
human
mous
cytokin
differ
cell
type
viral
rna
carri
use
iq
sybr
green
supermix
biorad
accord
manufactur
instruct
pcr
temperatur
profil
min
follow
cycl
express
level
individu
mrna
calcul
base
ct
valu
use
two
differ
housekeep
gene
human
atubulin
gene
mous
bactin
normal
data
one
pair
two
tail
student
ttest
use
analyz
data
data
consid
signific
demonstr
p
valu
less
